Leyden Labs announced the acquisition of RIGImmune technology and achieved positive Phase 1 trial results for RIG-101.
1 report, 1 independent
Updated Sep 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leyden Labs announced the acquisition of RIGImmune technology and achieved positive Phase 1 trial results for RIG-101.